1.95  -0.19 (-8.88%)		01-21 10:13
Open: 1.96 High: 2.2 Volume: 908,417		Pre. Close: 2.14 Low: 1.9 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	3.78	1-year :	5.18
Resists	First :	3.23	Second :	4.43
Pivot price	1.75
Supports	First :	1.28	Second :	1.07
MAs	MA(5) :	1.63	MA(20) :	1.77
	MA(100) :	2.74	MA(250) :	6.03
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	21.2	D(3) :	17.2
RSI	RSI(14): 59.1
52-week	High :	25.25	Low :	1.25

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SHPH ] has closed below upper band by 6.7%. Bollinger Bands are 15.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	4.45 - 4.46	4.46 - 4.48
Low:	2.06 - 2.07	2.07 - 2.08
Close:	2.12 - 2.14	2.14 - 2.15

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.

Tue, 20 Jan 2026
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Tue, 20 Jan 2026
Shuttle Pharmaceuticals’ Stock Surges Amid Strategic Developments - StocksToTrade

Tue, 20 Jan 2026
Shuttle Pharma Rockets Over 100% As AI Drug Discovery Gains Attention - Nasdaq

Tue, 20 Jan 2026
Shuttle Pharmaceuticals sees Reacts to Latest Financial Reports - timothysykes.com

Tue, 13 Jan 2026
Utah lets AI refill meds—and how a drug discovery platform fits this shift - Stock Titan

Thu, 08 Jan 2026
Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement - MSN

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	0 (M)
Shares Float	2 (M)
Held by Insiders	1.5e+006 (%)
Held by Institutions	3.2 (%)
Shares Short	194 (K)
Shares Short P.Month	0 (K)

EPS	-1.09e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-323.3 %
Return on Equity (ttm)	-27 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	374.85
EBITDA (p.s.)	0
Qtrly Earnings Growth	-3.5 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-11 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0.89

Dividend	0
Forward Dividend	160520
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.